Corvus Pharmaceuticals Ownership | Who Owns Corvus Pharmaceuticals?

Overview ForecastFinancials Chart Transcripts

Corvus Pharmaceuticals Ownership Summary

Corvus Pharmaceuticals is owned by 50.28% institutional investors, 3.80% insiders, and 45.91% retail investors. Orbimed advisors is the largest institutional shareholder, holding 10.41% of CRVS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.70% of its assets in Corvus Pharmaceuticals shares.

CRVS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Corvus Pharmaceuticals	50.28%	3.80%	45.91%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	6.94M	10.41%	$37.15M
Samlyn capital	6.67M	10.00%	$35.67M
Adams street partners	3.28M	4.91%	$17.52M
Point72 asset management	3.03M	4.54%	$16.21M
Rtw investments, lp	2.68M	4.02%	$14.34M
Vanguard group	2.45M	3.68%	$13.13M
Vivo capital	2.23M	3.35%	$11.95M
Foresite capital management vi	1.58M	2.37%	$8.46M
Blackrock funding, inc. /de	1.07M	1.61%	$5.74M
Susquehanna group, llp	1.02M	1.52%	$5.43M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Adams street partners	3.28M	15.53%	$17.52M
Foresite capital management vi	1.58M	3.77%	$8.46M
Vivo capital	2.23M	1.34%	$11.95M
Orbimed advisors	6.94M	0.77%	$37.15M
Samlyn capital	6.67M	0.54%	$35.67M
Sphera funds management	500.49K	0.48%	$2.68M
Towerview	77.50K	0.30%	$414.63K
Entrypoint capital	116.64K	0.26%	$624.05K
Rtw investments, lp	2.68M	0.22%	$14.34M
Masso torrence wealth management	30.00K	0.08%	$160.50K

Top Buyers

Holder	Shares	% Assets	Change
Rtw investments, lp	2.68M	0.22%	2.68M
Samlyn capital	6.67M	0.54%	2.14M
Foresite capital management vi	1.58M	3.77%	1.58M
Susquehanna group, llp	1.02M	0.00%	796.12K
Vivo capital	2.23M	1.34%	737.30K

Top Sellers

Holder	Shares	% Assets	Change
Point72 asset management	3.03M	0.04%	-2.53M
Deerfield management company, l.p. (series c)	-	-	-1.00M
Bvf inc/il	-	-	-361.41K
Marshall wace, llp	-	-	-323.21K
Schonfeld strategic advisors	129.08K	0.00%	-202.28K

New Positions

Holder	Shares	% Assets	Change	Value
Rtw investments, lp	2.68M	0.22%	2.68M	$14.34M
Foresite capital management vi	1.58M	3.77%	1.58M	$8.46M
Sphera funds management	500.49K	0.48%	500.49K	$2.68M
Entrypoint capital	116.64K	0.26%	116.64K	$624.05K
Raymond james financial	108.99K	0.00%	108.99K	$583.09K

Sold Out

Holder	Change
Parallel advisors	-20.00
Ifp advisors	-24.00
Eversource wealth advisors	-60.00
Ica group wealth management	-165.00
Signaturefd	-224.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	104	2.97%	36,268,523	-3.73%	50	1.58%	40	-41.18%	29	190.00%
Dec 31, 2024	100	38.89%	37,670,552	25.42%	56	2.79%	67	71.79%	10	-
Sep 30, 2024	70	40.00%	30,020,596	8.80%	45	1.42%	38	100.00%	10	-
Jun 30, 2024	50	-	27,591,708	54.15%	56	4.22%	19	-	10	-23.08%
Mar 31, 2024	50	-	17,899,766	-6.69%	36	2.38%	19	35.71%	13	18.18%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.84M	2.70%	222.07K
Vanguard US Total Market Shares ETF	1.58M	2.32%	-
Vanguard Institutional Extnd Mkt Idx Tr	793.14K	1.16%	-
Fidelity Extended Market Index	284.48K	0.42%	4.57K
iShares Biotechnology ETF	279.82K	0.36%	-3.66K
BlackRock Extended Equity Market K	104.43K	0.17%	30.20K
Extended Equity Market Fund K	103.33K	0.15%	317.00
Fidelity Total Market Index	96.75K	0.14%	6.21K
iShares Micro-Cap ETF	87.15K	0.11%	-
Fidelity Series Total Market Index	69.77K	0.10%	2.56K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 06, 2024	Thompson Peter A.		Buy	$4.89M
May 06, 2024	Thompson Peter A.		Buy	$144.41
May 06, 2024	ORBIMED ADVISORS LLC		Buy	$144.41
May 06, 2024	ORBIMED ADVISORS LLC		Buy	$4.89M
May 06, 2024	Jones William Benton	See Remarks	Buy	$34.62K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2024 Q4	-	-
2024 Q2	8	-
2024 Q1	-	-
2023 Q4	-	-

CRVS Ownership FAQ

Who Owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals shareholders are primarily institutional investors at 50.28%, followed by 3.80% insiders and 45.92% retail investors. The average institutional ownership in Corvus Pharmaceuticals's industry, Biotech Stocks , is 63.96%, which Corvus Pharmaceuticals falls below.

Who owns the most shares of Corvus Pharmaceuticals?

Corvus Pharmaceuticals’s largest shareholders are Orbimed advisors (6.94M shares, 10.41%), Samlyn capital (6.67M shares, 10.00%), and Adams street partners (3.28M shares, 4.91%). Together, they hold 25.32% of Corvus Pharmaceuticals’s total shares outstanding.

Does Blackrock own Corvus Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Corvus Pharmaceuticals.

Who is Corvus Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Adams street partners is Corvus Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 15.53% of its assets in 3.28M Corvus Pharmaceuticals shares, valued at 17.52M$.

Who is the top mutual fund holder of Corvus Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Corvus Pharmaceuticals shares, with 2.70% of its total shares outstanding invested in 1.84M Corvus Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools